NCT04738188View on ClinicalTrials.gov

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

NARecruitingINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

March 18, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2025

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

DEB-TACE

Drug-eluting beads transcatheter arterial chemoembolization

PROCEDURE

cTACE

Transcatheter arterial chemoembolization

DEVICE

Drug-eluting Beads

Drug-eluting beads

DRUG

Epirubicin

Chemotherapy drug for intra-arterial infusion

Trial Locations (1)

Unknown

RECRUITING

Beijing Tsinghua Chang Gung Hospital, Beijing

All Listed Sponsors
lead

Beijing Tsinghua Chang Gung Hospital

OTHER